Loading...
XSES
1H3
Market cap965kUSD
Jul 30, Last price  
0.00SGD
1D
0.00%
1Q
100.00%
IPO
-99.26%
Name

Clearbridge Health Ltd

Chart & performance

D1W1MN
XSES:1H3 chart
P/E
—
P/S
0.12
EPS
—
Div yield, %
—
Shrs. gr., 5y
40.51%
Rev. gr., 5y
-22.82%
Revenues
10m
+0.26%
213,865128,367123,000288,0006,135,00021,533,00036,258,00011,442,00016,412,00010,407,0009,903,0009,929,000
Net income
-13m
L+257.76%
4,728,7934,721,272-1,951,000-7,470,000-18,448,000-10,586,000615,000-19,970,000-11,144,000-32,199,000-3,608,000-12,908,000
CFO
-3m
L+37.62%
-2,860,734-2,881,009-5,754,000-6,766,000-10,213,000-8,635,0002,609,000-2,993,000-1,976,000-3,574,000-1,930,000-2,656,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

Established in 2010 and headquartered in Singapore, Clearbridge Health Limited operates as an investment holding company, delivering diverse healthcare solutions globally, including in Singapore, the Philippines, Hong Kong, and Malaysia. The firm's activities are organized into three key divisions: Strategic Investments, Healthcare Systems, and Medical Clinics/Centres. Its extensive range of services encompasses advanced imaging diagnostics, such as general X-ray, CT scans (including dental cone beam), mammography, MRI, and ultrasound. Furthermore, Clearbridge offers general wellness screenings for conditions like diabetes, high blood pressure, and elevated cholesterol, alongside vaccination programs. Specialized care includes renal treatment, clinical services, aesthetic procedures, and dental and orthodontic services. Beyond patient care, the company provides consultancy to healthcare organizations and is involved in the wholesale supply of medicinal and pharmaceutical products.
URL
https://www.clearbridgehealth.com/
IPO date
Dec 18, 2017
Employees
Domiciled in
SG
Incorporated in
SG

Valuation

Title
SGD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT